Earnings Summary

Cardinal Health, Inc.’s revenue jumped 8.76% since last year same period to $54911Mn in the Q1 2024. On a quarterly growth basis, Cardinal Health, Inc. has generated -4.41% fall in its revenue since last 3-months.

Cardinal Health, Inc.’s net profit fell -25.22% since last year same period to $258Mn in the Q1 2024. On a quarterly growth basis, Cardinal Health, Inc. has generated -26.91% fall in its net profits since last 3-months.

Cardinal Health, Inc.’s net profit margin fell -31.24% since last year same period to 0.47% in the Q1 2024. On a quarterly growth basis, Cardinal Health, Inc. has generated -23.54% fall in its net profit margins since last 3-months.

Cardinal Health, Inc.’s price-to-earnings ratio after this Q1 2024 earnings stands at 42.41.

Cardinal Health, Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.73 - a -11.28% fall from last quarter’s estimates.

Cardinal Health, Inc.’s earning per share (EPS) estimates for the current year stand at 1.73.

Cardinal Health, Inc.’s earning per share (EPS) jumped 19.54% since last year same period to 2.08 in the Q1 2024. This indicates that the Cardinal Health, Inc. has generated 19.54% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Cardinal Health, Inc.’s return on assets (ROA) stands at 0.03.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Cardinal Health, Inc.’s return on equity (ROE) stands at 0.

Cardinal Health, Inc. declared 0.5 dividend per share during the earnings announcement for Q1 2024.